Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001641172-25-006667
Filing Date
2025-04-29
Accepted
2025-04-29 16:45:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS form424b3.htm 424B3 112734
  Complete submission text file 0001641172-25-006667.txt   114078
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-286581 | Film No.: 25888618
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)